Health Midwest Oncology Associates of Kansas

Overland Park, Kansas 66211

0 studies enrolling now · 1 studies all time

What they study most

NSCLC

Studies at this site

• A Phase 2 Study of EIK1001 in Combo With Pembrolizumab and Chemotherapy in Patients With Stage 4 NSCLC — Running, not enrolling